HOOKIPA Pharma Inc. (HOOK)
1.52
-0.01 (-0.65%)
At close: Mar 03, 2025, 11:38 AM
HOOKIPA Pharma Cash Flow Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Net Income | n/a | -81.58M | -64.92M | -75.67M | -44.08M | -43.04M | -16.24M | -12.72M |
Depreciation & Amortization | n/a | 3.55M | 3.6M | 4.64M | 4.15M | 1.44M | 640K | 398K |
Stock-Based Compensation | n/a | 2.35M | 5.04M | 7.64M | 8.66M | 5.57M | 867K | 770K |
Other Working Capital | n/a | -4.62M | 38.45M | 1.42M | 511K | -4.44M | 8.59M | 859K |
Other Non-Cash Items | -76.98M | 12.83M | 160K | 1.23M | 53K | 1.68M | 7K | -45K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 5.33M | 36.11M | -3.86M | -8.12M | -7.38M | -275K | -313K |
Operating Cash Flow | -76.98M | -57.52M | -20M | -66.02M | -39.34M | -41.73M | -15M | -11.91M |
Capital Expenditures | n/a | -4.16M | -5.02M | -12.58M | -2.37M | -2M | -2.15M | -1.3M |
Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -194K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -194K | -4.16M | -5.02M | -12.58M | -2.37M | -2M | -2.15M | -1.3M |
Debt Repayment | n/a | -1.75M | -2.85M | -438K | -1.42M | -2.28M | 425K | 747K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1.28M | 18.53M | 29.43M | n/a | 32.2M | 37.27M | 12.89M | 116.29M |
Financial Cash Flow | -1.28M | 65.67M | 72.27M | -235K | 73.42M | 109.75M | 6.87M | 58.89M |
Net Cash Flow | -78.45M | 4.08M | 46.53M | -76.27M | 29.6M | 65M | -12.78M | 48.18M |
Free Cash Flow | -76.98M | -61.68M | -25.01M | -78.6M | -41.71M | -43.73M | -17.15M | -13.21M |